PointState Capital’s Oracle ORCL Stock Holding History

PointState Capital’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-360,000	Closed	-$45.2M	–	78
2024 Q1	$45.2M	Buy	+360,000	New	+$41.2M	0.77%	36

Other funds holding ORCL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PointState Capital's ORCL Position: Q2 2024 in Review

PointState Capital sold out of Oracle (ORCL) in Q2 2024, closing a stake of 848,968 shares — an estimated $107M sold.

PointState Capital first reported a position in ORCL in Q4 2015 and held it in 4 quarters. The position peaked at $107M in Q1 2024. 2,916 funds tracked by Wall St. Rank hold ORCL as of Q2 2024.

PointState Capital reported no remaining Oracle position as of Q2 2024 after selling out during the quarter.
PointState Capital sold 848,968 Oracle shares in Q2 2024, an estimated $107M.
PointState Capital first reported a position in Oracle in Q4 2015 and held it in 4 quarters.
PointState Capital's Oracle position peaked at $107M in Q1 2024.
2,916 funds tracked by Wall St. Rank held Oracle as of Q2 2024.

Based on PointState Capital's 13F filing for Q2 2024, filed 14 Aug 2024.